Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydrogen ion buffering capacity in skeletal muscle refers to the tissue’s ability to attenuate decreases in pH during high-intensity exercise via multiple intracellular (e.g., proteins, carnosine, phosphates) and extracellular (e.g., bicarbonate in blood) chemical buffers, as well as by membrane transport systems such as the sodium–hydrogen exchanger (NHE), sodium–bicarbonate co-transporter (NBC), and monocarboxylate transporters (MCTs) which extrude protons from muscle fibers. Enhanced buffering capacity can delay muscle fatigue by protecting enzymes and contractile proteins from acidosis-induced dysfunction, and is influenced by training status, muscle fiber type, nutritional interventions (e.g., beta-alanine, bicarbonate), and genetics[1][2][3][4][5][6][7][9].
Extracellular alkalosis (bicarbonate/citrate supplements) increases extracellular buffering, enhances H⁺ efflux from muscle, and delays acidosis/fatigue[5][9]. Beta-alanine increases muscle carnosine, augmenting intracellular pH buffering[9].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrogen ion buffering capacity in skeletal muscle.